This list is based on the watchlists of people on Stock Events who follow 298380.KQ. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company offers ABL301, which is in the phase 1 clinical stage for the treatment of parkinson's disease; ABL503 and ABL111 that is in phase 1 clinical stage for the treatment of solid tumor; and ABL102 for the treatment of solid and blood tumor. It also provides ABL103 for the treatment solid cancers; ABL104 for the treatment of solid tumor; and ABL105, which is in phase 1 clinical stage for the treatment of solid tumor. ABL Bio Inc. was incorporated in 2016 and is based in Seoul, South Korea.
Show more...
FAQ
What is ABL Bio stock price today?▼
The current price of 298380.KQ is ₩153,300 KRW — it has increased by +2.68% in the past 24 hours. Watch ABL Bio stock price performance more closely on the chart.
What is ABL Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ABL Bio stocks are traded under the ticker 298380.KQ.
Is ABL Bio stock price growing?▼
298380.KQ stock has fallen by -6.41% compared to the previous week, the month change is a -9.18% fall, over the last year ABL Bio has showed a +120.89% increase.
What is ABL Bio market cap?▼
Today ABL Bio has the market capitalization of 8.45T
What is ABL Bio revenue for the last year?▼
ABL Bio revenue for the last year amounts to 79.35B KRW.
What is ABL Bio net income for the last year?▼
298380.KQ net income for the last year is -9.64B KRW.
In which sector is ABL Bio located?▼
ABL Bio operates in the Energy sector.
When did ABL Bio complete a stock split?▼
ABL Bio has not had any recent stock splits.
Where is ABL Bio headquartered?▼
ABL Bio is headquartered in Seoul, South Korea.